Atrophine dextrose heparin hydralazine

Ended Awarded Last action

Contract number
HT001422F0083
Awardee
Awarding agency
Obligated
$65,000

Award facts

Contract value 100% obligated
$65,000.00 Current and potential, with all options
Completion date
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a firm fixed price blanket purchase agreement call contract valued at sixty-five thousand dollars to The Compounding Center Inc. of Bethesda, Maryland. The contract is for the delivery of ATROPHINE DEXTROSE HEPARIN HYDRALAZINE with no set-aside designation applied. The place of performance is Bethesda, Maryland and the completion date is March 16, 2022, which is also the award date. No major subcontractors were identified. The Defense Health Agency supports the military health system and ensures a medically ready force and ready medical force through the delivery of integrated, affordable, and high quality health services.

Quick answers

Who was awarded contract HT001422F0083?

HT001422F0083 was awarded to The Compounding Center Inc. by Defense Health Agency (Department of Defense) on March 16, 2022.

How much is contract HT001422F0083 worth?

The government has obligated $65,000 on HT001422F0083.

Is contract HT001422F0083 an order under another contract?

Yes. HT001422F0083 is a BPA call under HT001420A0018, a blanket purchase agreement.

Was contract HT001422F0083 competed?

The extent of competition for HT001422F0083 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award